title: Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma.
abstract: BACKGROUND
  Alpha-enolase is a glycolytic enzyme that catalyses the formation of phosphoenolpyruvate in the cell cytoplasm. α-Enolase and the predominantly nuclear Myc promoter-binding protein-1 (MBP-1) originate from a single gene through the alternative use of translational starting sites. MBP-1 binds to the P2 c-myc promoter and competes with TATA-box binding protein (TBP) to suppress gene transcription. Although several studies have shown an antiproliferative effect of MBP-1 overexpression on several human cancer cells, to date detailed observations of α-enolase and MBP-1 relative expression in primary tumors versus normal tissues and their correlation with clinicopathological features have not been undertaken.
  
  
  RESULTS
  We analyzed α-enolase and MBP-1 expression in normal breast epithelium and primary invasive ductal breast carcinoma (IDC) from 177 patients by Western blot and immunohistochemical analyses, using highly specific anti-α-enolase monoclonal antibodies. A significant increase in the expression of cytoplasmic α-enolase was observed in 98% of the tumors analysed, compared to normal tissues. Nuclear MBP-1 was found in almost all the normal tissues while its expression was retained in only 35% of the tumors. Statistically significant associations were observed among the nuclear expression of MBP-1 and ErbB2 status, Ki-67 expression, node status and tumor grade. Furthermore MBP-1 expression was associated with good survival of patients with IDC.
  
  
  CONCLUSIONS
  MBP-1 functions in repressing c-myc gene expression and the results presented indicate that the loss of nuclear MBP-1 expression in a large number of IDC may be a critical step in the development and progression of breast cancer and a predictor of adverse outcome. Nuclear MBP-1 appears to be a novel and valuable histochemical marker with potential prognostic value in breast cancer.
authors.affiliation: Dipartimento di Oncologia Sperimentale e Applicazioni Cliniche, Università di Palermo, Palermo, Italy.
authors.forename: Mariavera
authors.initials: M
authors.lastname: Lo Presti
authors.forename: Arianna
authors.initials: A
authors.lastname: Ferro
authors.forename: Flavia
authors.initials: F
authors.lastname: Contino
authors.forename: Claudia
authors.initials: C
authors.lastname: Mazzarella
authors.forename: Silvia
authors.initials: S
authors.lastname: Sbacchi
authors.forename: Elena
authors.initials: E
authors.lastname: Roz
authors.forename: Carmelo
authors.initials: C
authors.lastname: Lupo
authors.forename: Giovanni
authors.initials: G
authors.lastname: Perconti
authors.forename: Agata
authors.initials: A
authors.lastname: Giallongo
authors.forename: Paola
authors.initials: P
authors.lastname: Migliorini
authors.forename: Antonio
authors.initials: A
authors.lastname: Marrazzo
authors.forename: Salvatore
authors.initials: S
authors.lastname: Feo
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D044584:Carcinoma, Ductal / Q000175:diagnosis* / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D002467:Cell Nucleus / Q000235:genetics / Q000378:metabolism; D003593:Cytoplasm / Q000201:enzymology / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics* / Q000378:metabolism; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D010751:Phosphopyruvate Hydratase / Q000235:genetics / Q000378:metabolism; D011379:Prognosis; D021381:Protein Transport
chemical_list: D014408:Biomarkers, Tumor; C088830:DENND4A protein, human; D004268:DNA-Binding Proteins; D010751:Phosphopyruvate Hydratase